Perioperative management of pancreatic exocrine insufficiency–evidence-based proposal for a paradigm shift in pancreatic surgery
HPB · 2024
DOI: 10.1016/j.hpb.2023.09.003 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift HPB, 2024. Verfasst von Louisa Stern und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. Electr…. Hauptthemen laut MEDLINE: Exocrine Pancreatic Insufficiency, Digestive System Surgical Procedures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Despite exocrine pancreatic insufficiency (EPI) being a significant consequence of pancreatic surgery, there is still no consensus on its perioperative management. This study aimed to evaluate unselective pancreatic enzyme replacement therapy (PERT). METHODS: A prospective, observational study of patients undergoing partial pancreatectomy was conducted. EPI status was assessed pre- and postoperatively, based on three fecal-elastase measurements each. Characteristic symptoms were evaluated by questionnaire. In 85 post-surgical patients, the subjective burden of PERT was measured. RESULTS: 101 patients were followed prospectively. Preoperative EPI screening was available for 83 patients, of which 48% were diagnosed with preexisting EPI. Of those patients with regular exocrine function, 54% developed EPI de novo; this rate being higher following pancreatic head resections (72%) compared to left-sided pancreatectomies (LP) (20%) (p = 0.016). Overall postoperative EPI prevalence was significantly greater following pancreatic head resections (86%) than LP (33%) (p < 0.001). Only young and female patients described a significant burden related to PERT. CONCLUSION: For all patients undergoing pancreatic head resection PERT should be considered beginning prior to surgery, due to the subgroup's high EPI rate and the comparatively low burden of PERT. Patients with LP are at lower risk and should be pre- and postoperatively screened and supplemented accordingly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. Electronic address: l.stern@uke.de.
- Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
- Department of Internal Medicine and Gastroenterology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
- Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Zitieren
APA
Stern, L., Schuette, M., Goetz, M. R., Nitschke, C., Bardenhagen, J., Scognamiglio, P., Stüben, B. O., Calavrezos, L., Amin, T., Heumann, A., Lohse, A. W., de Heer, G., Izbicki, J. R., & Uzunoglu, F. G. (2024). Perioperative management of pancreatic exocrine insufficiency–evidence-based proposal for a paradigm shift in pancreatic surgery. HPB. https://doi.org/10.1016/j.hpb.2023.09.003
Vancouver
Stern L, Schuette M, Goetz MR, Nitschke C, Bardenhagen J, Scognamiglio P, et al. Perioperative management of pancreatic exocrine insufficiency–evidence-based proposal for a paradigm shift in pancreatic surgery. HPB. 2024. doi:10.1016/j.hpb.2023.09.003
BibTeX
@article{Stern2024,
author = {Stern, Louisa and Schuette, Miriam and Goetz, Mara R and Nitschke, Christine and Bardenhagen, Jan and Scognamiglio, Pasquale and Stüben, Björn-Ole and Calavrezos, Lenika and Amin, Tania and Heumann, Asmus and Lohse, Ansgar W and de Heer, Geraldine and Izbicki, Jakob R and Uzunoglu, Faik G},
title = {Perioperative management of pancreatic exocrine insufficiency–evidence-based proposal for a paradigm shift in pancreatic surgery},
journal = {HPB},
year = {2024},
doi = {10.1016/j.hpb.2023.09.003}
}
EUVIMED